Cargando…

The protective capability of Hedyotis diffusa Willd on lupus nephritis by attenuating the IL-17 expression in MRL/lpr mice

Lupus nephritis (LN), the most severe organ manifestation of systemic lupus erythematosus (SLE), is generally treated with glucocorticoids (GC) in clinical practice, leading to drug resistance and adverse effects in the long term. Fortunately, the combination of GC and traditional Chinese medical pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ying, Ding, Tao, Chen, Jing, Ji, Jinjun, Wang, Weijie, Ding, Bin, Ge, Weihong, Fan, Yongsheng, Xu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359319/ https://www.ncbi.nlm.nih.gov/pubmed/35958622 http://dx.doi.org/10.3389/fimmu.2022.943827

Ejemplares similares

The Antitumor Constituents from Hedyotis Diffusa Willd
por: Wang, Changfu, et al.
Publicado: (2017)

Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology
por: Yang, Jinfei, et al.
Publicado: (2023)

Exploring the mechanism of action of Hedyotis diffusa Willd on acne using network analysis
por: Seo, Gwangyeel, et al.
Publicado: (2023)

ALW peptide ameliorates lupus nephritis in MRL/lpr mice
por: Wang, Huixia, et al.
Publicado: (2019)

The Hedyotis diffusa Willd. (Rubiaceae): A Review on Phytochemistry, Pharmacology, Quality Control and Pharmacokinetics
por: Chen, Rui, et al.
Publicado: (2016)

Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts
por: Wu, Zihong, et al.
Publicado: (2022)

The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
por: Shi, Yu, et al.
Publicado: (2019)

Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating AKT/mTOR Pathways
por: Huang, Lingli, et al.
Publicado: (2021)

Inhibitory effects of total triterpenoids isolated from the Hedyotis diffusa willd on H1975 cells
por: Wu, Kenan, et al.
Publicado: (2022)

Therapeutic effects of Hedyotis diffusa Willd in a COPD mouse model challenged with LPS and smoke
por: Liu, Renping, et al.
Publicado: (2018)

Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of Hedyotis diffusa Willd in Liver Cancer
por: Wu, Hongyan, et al.
Publicado: (2023)

Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice
por: Ye, Jian-Hong, et al.
Publicado: (2015)

A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer
por: Liu, Xinkui, et al.
Publicado: (2018)

Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer
por: Liu, Xinkui, et al.
Publicado: (2018)

Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment
Publicado: (1991)

Protective Effect of Hedyotis diffusa Willd. Ethanol Extract on Isoniazid-Induced Liver Injury in the Zebrafish Model
por: Wang, Xin, et al.
Publicado: (2022)

Network pharmacology and experimental validation to identify the potential mechanism of Hedyotis diffusa Willd against rheumatoid arthritis
por: Deng, Hui, et al.
Publicado: (2023)

Mechanism of Hedyotis Diffusa in the Treatment of Cervical Cancer
por: Qian, Kai, et al.
Publicado: (2021)

Hedyotis diffusa Willd Inhibits Colorectal Cancer Growth in Vivo via Inhibition of STAT3 Signaling Pathway
por: Cai, Qiaoyan, et al.
Publicado: (2012)

Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo
por: Kuo, Yu-Jui, et al.
Publicado: (2017)

Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach
por: Song, Yanan, et al.
Publicado: (2019)

Chemical Constituents of Hedyotis diffusa and Their Anti-Inflammatory Bioactivities
por: Hung, Hsin-Yi, et al.
Publicado: (2022)

Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
por: Keil, Andreas, et al.
Publicado: (2016)

Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice
por: Liu, Jingqun, et al.
Publicado: (2022)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)

Ethyl Acetate Fraction of Hedyotis diffusa Willd Induces Apoptosis via JNK/Nur77 Pathway in Hepatocellular Carcinoma Cells
por: Ning, Weimin, et al.
Publicado: (2022)

Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis
por: Sato, Shuzo, et al.
Publicado: (2020)

Discovery of the Potential Biomarkers for Discrimination between Hedyotis diffusa and Hedyotis corymbosa by UPLC-QTOF/MS Metabolome Analysis
por: Wang, Yaru, et al.
Publicado: (2018)

Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice
por: Nakatani, Kimihiko, et al.
Publicado: (2013)

Reduced receptor editing in lupus-prone MRL/lpr mice
por: Lamoureux, Jennifer L., et al.
Publicado: (2007)

Hedyotis diffusa Willd. extract suppresses proliferation and induces apoptosis via IL-6-inducible STAT3 pathway inactivation in human colorectal cancer cells
por: LIN, JIUMAO, et al.
Publicado: (2015)

Anti-RNA polymerase I antibodies in sera of MRL lpr/lpr and MRL +/+ autoimmune mice. Correlation of antibody production with delayed onset of lupus-like disease in MRL +/+ mice
Publicado: (1985)

Reno-protective effect and mechanism study of Huang Lian Jie Du Decoction on lupus nephritis MRL/lpr mice
por: Nie, Xiaoli, et al.
Publicado: (2016)

Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice
por: Hong, Seung-Min, et al.
Publicado: (2020)

Murine lupus is neutrophil elastase-independent in the MRL.Fas(lpr) model
por: Gordon, Rachael A., et al.
Publicado: (2020)

Prevention of nephritis in major histocompatibility complex class II- deficient MRL-lpr mice
Publicado: (1994)

Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL/lpr Mice
por: Yan, Qingran, et al.
Publicado: (2014)

Preclinical Pharmacokinetic Interaction and Histopathological Analyses of Hedyotis diffusa on Sorafenib in Rats
por: Ting, Chin-Tsung, et al.
Publicado: (2021)

P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI
por: Zhang, Liwen, et al.
Publicado: (2020)

Self-Reactivity and the Expression of Memory Markers Vary Independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr Mice
por: Smyth, Lesley, et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_4j808n4rol2n4rgdg4iqm7r4fg